MetaCap

Sight Sciences (SGHT) vs vVARDIS (VVVV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

vVARDIS is the larger company by market cap ($770.9 million vs $565.8 million), about 1.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SGHT-6.00%VVVV-11.82%
+1%-6%-12%
Nov 13, 20261 yearNov 20, 2026
SGHT-6.00%VVVV-11.82%
+1%-6%-12%
Nov 9, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SGHT versus VVVV key metrics
MetricSGHTVVVV
Share price$10.18$14.55
Market cap$565.79M$770.91M
1-day change-4.14%-3.00%
YTD return+28.37%—
1-year return+40.22%—
5-year return-46.67%—
EPS (TTM)$-0.52$-0.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$77.36M—
Revenue growth (YoY)-3.13%—
Net income (latest FY)$-38.43M—
Gross margin86.17%—
Operating margin-47.95%—
Net margin-49.67%—
52-week high$11.60$16.95
52-week low$3.38$14.00
Distance from 52-week high-12.20%-14.16%
Analyst consensusbuy—
Avg. price target upside+20.33%—
Average volume313.51K963.08K
Shares outstanding55.58M38.59M
Employees186153
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Sight Sciences

SGHT stock →

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.

Health Care · Medical/Dental Instruments · 186 employees

About vVARDIS

VVVV stock →

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.

Health Care · Medical/Dental Instruments · 153 employees

SGHT vs VVVV FAQ

Which is bigger, Sight Sciences or vVARDIS?

vVARDIS (VVVV) is larger, with a market capitalization of $770.91M compared with $565.79M for Sight Sciences (SGHT).

Are Sight Sciences and vVARDIS in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons